China NT Pharma Group Co., Ltd.'s market cap is currently HK$148.15M. The company's EPS TTM is HK$; its P/E ratio is ―; China NT Pharma Group Co., Ltd. is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 7.37M	¥ 207.09M	¥ 226.70M	¥ 221.73M	¥ 365.97M
Gross Profit	¥ 7.37M	¥ 125.29M	¥ 145.46M	¥ 134.90M	¥ 260.88M
Operating Income	¥ 0.00	¥ 18.44M	¥ -59.28M	¥ -68.13M	¥ -22.05M
EBITDA	¥ 1.33M	¥ 10.39M	¥ -17.78M	¥ -43.74M	¥ -155.97M
Net Income	¥ -143.59M	¥ -66.41M	¥ -151.33M	¥ -191.27M	¥ -593.20M
Balance Sheet
Cash & Short-Term Investments	¥ 1.52M	¥ 5.93M	¥ 9.44M	¥ 7.69M	¥ 72.99M
Total Assets	¥ 329.12M	¥ 1.01B	¥ 955.36M	¥ 1.30B	¥ 1.80B
Total Debt	¥ 344.94M	¥ 826.45M	¥ 832.11M	¥ 851.46M	¥ 1.03B
Net Debt	¥ 343.42M	¥ 820.52M	¥ 822.67M	¥ 843.76M	¥ 999.41M
Total Liabilities	¥ 668.69M	¥ 1.25B	¥ 1.17B	¥ 1.27B	¥ 1.70B
Stockholders' Equity	¥ -339.56M	¥ -241.66M	¥ -211.38M	¥ 16.28M	¥ 105.26M
Cash Flow
Free Cash Flow	¥ 37.58M	¥ 31.72M	¥ -135.42M	¥ 2.36M	¥ -39.44M
Operating Cash Flow	¥ 50.48M	¥ 36.21M	¥ -134.78M	¥ 26.20M	¥ 47.77M
Investing Cash Flow	¥ -22.14M	¥ 4.53M	¥ 257.81M	¥ 595.60M	¥ -206.88M
Financing Cash Flow	¥ -28.97M	¥ -46.68M	¥ -124.80M	¥ -624.25M	¥ 101.37M

Currency in CNY

China NT Pharma Group Co., Ltd. Earnings and Revenue History

Income Statement >

China NT Pharma Group Co., Ltd. Debt to Assets

Balance Sheet >

China NT Pharma Group Co., Ltd. Cash Flow

Cash Flow >

China NT Pharma Group Co., Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing